Dose/Strength | 2.5 mg |
Usage/Application | Hospital |
Brand | femara2.5 |
Packaging Size | 10x3 |
Packaging Type | Box |
Letrozole Tablets, USP are aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer ( 1.1) Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy ( 1.2)
Additional Information:
- Delivery Time: 1 day
- Packaging Details: 3x10